FDA.reportPublic FDA data

Hyqvia 400 UNT per 2.5 ML / 5 G per 50 ML (10 % ) Kit

RxCUI
1549692
RxNorm name
Hyqvia 400 UNT per 2.5 ML / 5 G per 50 ML (10 % ) Kit
Display name
Hyqvia 400 UNT per 2.5 ML / 5 G per 50 ML (10 % ) Kit
Full name
Hyqvia 400 UNT per 2.5 ML / 5 G per 50 ML (10 % ) Kit
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125402HyqviaImmune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7ca2c26f-4be2-48cd-be5b-486e350654baHyqvia 400 UNT per 2.5 ML / 5 G per 50 ML (10 % ) KitSY22These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204
7ca2c26f-4be2-48cd-be5b-486e350654ba{1 (2.5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (50 ML immunoglobulin G, human 100 MG/ML Injection) } Pack [Hyqvia 5 G / 50 ML Kit]BPCK22These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204
7ca2c26f-4be2-48cd-be5b-486e350654baHYQVIA 5 GM / 50 ML KitPSN22These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204